3/31
05:16 pm
kod
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Low
Report
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
3/31
04:58 pm
kod
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results [TheStreet.com]
Low
Report
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results [TheStreet.com]
3/31
04:53 pm
kod
Kodiak Sciences GAAP EPS of -$1.04 in-line [Seeking Alpha]
Low
Report
Kodiak Sciences GAAP EPS of -$1.04 in-line [Seeking Alpha]
3/31
04:45 pm
kod
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
Low
Report
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
3/28
03:35 pm
kod
Kodiak Sciences (KOD) Is Up 66.3% After Strong Zenkuda GLOW2 Phase 3 Data - Has The Bull Case Changed? [Yahoo! Finance]
High
Report
Kodiak Sciences (KOD) Is Up 66.3% After Strong Zenkuda GLOW2 Phase 3 Data - Has The Bull Case Changed? [Yahoo! Finance]
3/27
12:02 pm
kod
Kodiak Sciences: Shares Up On Positive Eye Disease Data - But I Remain On Sidelines [Seeking Alpha]
Low
Report
Kodiak Sciences: Shares Up On Positive Eye Disease Data - But I Remain On Sidelines [Seeking Alpha]
3/27
11:52 am
kod
Kodiak Sciences (KOD) had its price target raised by UBS Group AG from $50.00 to $80.00. They now have a "buy" rating on the stock.
High
Report
Kodiak Sciences (KOD) had its price target raised by UBS Group AG from $50.00 to $80.00. They now have a "buy" rating on the stock.
3/27
08:02 am
kod
Kodiak Sciences (KOD) had its "buy" rating reaffirmed by HC Wainwright. They now have a $58.00 price target on the stock, up from $38.00.
Medium
Report
Kodiak Sciences (KOD) had its "buy" rating reaffirmed by HC Wainwright. They now have a $58.00 price target on the stock, up from $38.00.
3/26
11:40 pm
kod
Kodiak Sciences (KOD) CLimbs 75% on Stellar Clinical Results [Yahoo! Finance]
Medium
Report
Kodiak Sciences (KOD) CLimbs 75% on Stellar Clinical Results [Yahoo! Finance]
3/26
06:26 am
kod
Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham [Yahoo! Finance]
High
Report
Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham [Yahoo! Finance]
3/26
06:00 am
kod
Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham
High
Report
Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham
3/14
07:22 pm
kod
Assessing Kodiak Sciences (KOD) Valuation After Recent Share Price Weakness And Strong One Year Return [Yahoo! Finance]
Low
Report
Assessing Kodiak Sciences (KOD) Valuation After Recent Share Price Weakness And Strong One Year Return [Yahoo! Finance]
3/9
10:19 am
kod
Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing [Yahoo! Finance]
Medium
Report
Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing [Yahoo! Finance]
2/24
06:33 am
kod
A Look At Kodiak Sciences (KOD) Valuation After Its Strong One Year Shareholder Return [Yahoo! Finance]
Medium
Report
A Look At Kodiak Sciences (KOD) Valuation After Its Strong One Year Shareholder Return [Yahoo! Finance]
2/10
08:05 am
kod
Kodiak Sciences (NASDAQ:KOD) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
Medium
Report
Kodiak Sciences (NASDAQ:KOD) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
2/4
07:22 am
kod
Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026 [Yahoo! Finance]
Medium
Report
Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026 [Yahoo! Finance]
2/4
07:00 am
kod
Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026
Medium
Report
Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026
2/3
08:00 am
kod
Kodiak Sciences: A Stellar Move [Seeking Alpha]
Low
Report
Kodiak Sciences: A Stellar Move [Seeking Alpha]
1/22
07:19 am
kod
Kodiak Sciences (NASDAQ:KOD) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Kodiak Sciences (NASDAQ:KOD) had its "buy" rating reaffirmed by analysts at HC Wainwright.
1/12
07:26 am
kod
3 Small-Cap Blend Mutual Funds With Strong Growth Potential [Yahoo! Finance]
Medium
Report
3 Small-Cap Blend Mutual Funds With Strong Growth Potential [Yahoo! Finance]
1/11
11:41 am
kod
Is It Too Late To Consider Kodiak Sciences (KOD) After Its 233% One-Year Surge? [Yahoo! Finance]
Low
Report
Is It Too Late To Consider Kodiak Sciences (KOD) After Its 233% One-Year Surge? [Yahoo! Finance]
1/9
06:10 am
kod
Kodiak Sciences (NASDAQ:KOD) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Medium
Report
Kodiak Sciences (NASDAQ:KOD) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
1/7
09:12 pm
kod
Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/7
08:19 pm
kod
Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference
1/7
02:01 am
kod
Kodiak Sciences (NASDAQ:KOD) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
Medium
Report
Kodiak Sciences (NASDAQ:KOD) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.